XML 94 R85.htm IDEA: XBRL DOCUMENT
v3.20.2

Licenses and collaborative arrangement (Details) $ in Thousands | 1 Months Ended | 6 Months Ended
--- | --- | ---
Apr. 30, 2020 USD ($) | Jul. 31, 2019 USD ($) | Jun. 30, 2019 USD ($) | Nov. 30, 2018 USD ($) Milestone | Sep. 30, 2018 USD ($) | May 31, 2018 USD ($) | Apr. 30, 2018 USD ($) Milestone | Dec. 31, 2017 USD ($) | Apr. 30, 2017 USD ($) Milestone | Sep. 30, 2016 USD ($) Milestone | Jun. 30, 2020 USD ($)
Maximum |  |  |  |  |  |  |  |  |  |  |
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] |  |  |  |  |  |  |  |  |  |  |
Future milestone payments to be made upon achievement |  |  |  |  |  |  |  |  |  |  | $ 1,533,344
Tesaro |  |  |  |  |  |  |  |  |  |  |
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] |  |  |  |  |  |  |  |  |  |  |
License agreement date |  |  |  |  |  |  |  |  |  | 2016-09 |
Payment of upfront fees |  |  |  |  |  |  |  |  |  | $ 15,000 |
Number of milestone payments | Milestone |  |  |  |  |  |  |  |  |  | 2 |
Milestone payments |  |  |  |  |  |  |  |  |  | $ 4,500 |
Tesaro | Maximum |  |  |  |  |  |  |  |  |  |  |
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] |  |  |  |  |  |  |  |  |  |  |
Additional milestone payments |  |  |  |  |  |  |  |  |  | $ 36,000 |
Paratek |  |  |  |  |  |  |  |  |  |  |
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] |  |  |  |  |  |  |  |  |  |  |
License agreement date |  |  |  |  |  |  |  |  | 2017-04 |  |
Payment of upfront fees |  |  |  |  |  |  |  |  | $ 7,500 |  |
Number of milestone payments | Milestone |  |  |  |  |  |  |  |  | 2 |  |
Milestone payments |  |  |  |  |  |  |  |  | $ 8,000 |  |
Paratek | Maximum |  |  |  |  |  |  |  |  |  |  |
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] |  |  |  |  |  |  |  |  |  |  |
Additional milestone payments |  |  |  |  |  |  |  |  | $ 46,500 |  |
Five Prime |  |  |  |  |  |  |  |  |  |  |
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] |  |  |  |  |  |  |  |  |  |  |
License agreement date |  |  |  |  |  |  |  | 2017-12 |  |  |
Payment of upfront fees |  |  |  |  |  |  |  | $ 5,000 |  |  |
Milestone payments |  |  |  |  |  |  |  | 2,000 |  |  |
Five Prime | Maximum |  |  |  |  |  |  |  |  |  |  |
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] |  |  |  |  |  |  |  |  |  |  |
Additional milestone payments |  |  |  |  |  |  |  | $ 37,000 |  |  |
Entasis |  |  |  |  |  |  |  |  |  |  |
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] |  |  |  |  |  |  |  |  |  |  |
License agreement date |  |  |  |  |  |  | 2018-04 |  |  |  |
Payment of upfront fees |  |  |  |  |  |  | $ 5,000 |  |  |  |
Number of milestone payments | Milestone |  |  |  |  |  |  | 2 |  |  |  |
Milestone payments |  |  |  |  |  |  | $ 7,000 |  |  |  |
Entasis | Maximum |  |  |  |  |  |  |  |  |  |  |
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] |  |  |  |  |  |  |  |  |  |  |
Additional milestone payments |  |  |  |  |  |  | $ 91,600 |  |  |  |
Crescendo |  |  |  |  |  |  |  |  |  |  |
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] |  |  |  |  |  |  |  |  |  |  |
License agreement date |  |  |  |  |  | 2018-05 |  |  |  |  |
Payment of upfront fees |  |  |  |  |  | $ 2,000 |  |  |  |  |
Milestone payments |  |  |  |  |  | 1,000 |  |  |  |  |
Crescendo | Maximum |  |  |  |  |  |  |  |  |  |  |
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] |  |  |  |  |  |  |  |  |  |  |
Additional milestone payments |  |  |  |  |  | $ 168,575 |  |  |  |  |
Novocure |  |  |  |  |  |  |  |  |  |  |
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] |  |  |  |  |  |  |  |  |  |  |
License agreement date |  |  |  |  | 2018-09 |  |  |  |  |  |
Payment of upfront fees |  |  |  |  | $ 15,000 |  |  |  |  |  |
Milestone payments |  |  |  |  | 2,000 |  |  |  |  |  |
Accrued milestone payment |  |  |  |  | 8,000 |  |  |  |  |  |
Novocure | Maximum |  |  |  |  |  |  |  |  |  |  |
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] |  |  |  |  |  |  |  |  |  |  |
Additional milestone payments |  |  |  |  | $ 68,000 |  |  |  |  |  |
MacroGenics |  |  |  |  |  |  |  |  |  |  |
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] |  |  |  |  |  |  |  |  |  |  |
License agreement date |  |  |  | 2018-11 |  |  |  |  |  |  |
Payment of upfront fees |  |  |  | $ 25,000 |  |  |  |  |  |  |
Number of milestone payments | Milestone |  |  |  | 2 |  |  |  |  |  |  |
Milestone payments |  |  |  | $ 4,000 |  |  |  |  |  |  |
MacroGenics | Maximum |  |  |  |  |  |  |  |  |  |  |
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] |  |  |  |  |  |  |  |  |  |  |
Additional milestone payments |  |  |  | $ 136,000 |  |  |  |  |  |  |
Deciphera |  |  |  |  |  |  |  |  |  |  |
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] |  |  |  |  |  |  |  |  |  |  |
License agreement date |  |  | 2019-06 |  |  |  |  |  |  |  |
Payment of upfront fees |  |  | $ 20,000 |  |  |  |  |  |  |  |
Milestone payments |  |  | 5,000 |  |  |  |  |  |  |  |
Accrued milestone payment |  |  | 2,000 |  |  |  |  |  |  |  |
Deciphera | Maximum |  |  |  |  |  |  |  |  |  |  |
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] |  |  |  |  |  |  |  |  |  |  |
Additional milestone payments |  |  | $ 178,000 |  |  |  |  |  |  |  |
Incyte |  |  |  |  |  |  |  |  |  |  |
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] |  |  |  |  |  |  |  |  |  |  |
License agreement date |  | 2019-07 |  |  |  |  |  |  |  |  |
Payment of upfront fees |  | $ 17,500 |  |  |  |  |  |  |  |  |
Incyte | Maximum |  |  |  |  |  |  |  |  |  |  |
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] |  |  |  |  |  |  |  |  |  |  |
Additional milestone payments |  | $ 60,000 |  |  |  |  |  |  |  |  |
Regeneron |  |  |  |  |  |  |  |  |  |  |
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] |  |  |  |  |  |  |  |  |  |  |
License agreement date | 2020-04 |  |  |  |  |  |  |  |  |  |
Payment of upfront fees | $ 30,000 |  |  |  |  |  |  |  |  |  |
Regeneron | Maximum |  |  |  |  |  |  |  |  |  |  |
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] |  |  |  |  |  |  |  |  |  |  |
Additional milestone payments | $ 160,000 |  |  |  |  |  |  |  |  |  |

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount represents accrued milestone payment. + References No definition available. + Details
Name: | zlab_AccruedMilestonePayment
Namespace Prefix: | zlab_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The amount represents the additional milestone payments. + References No definition available. + Details
Name: | zlab_AdditionalMilestonePayments
Namespace Prefix: | zlab_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Future contingent milestone payments to be made upon achievement. + References No definition available. + Details
Name: | zlab_FutureContingentMilestonePaymentsToBeMadeUponAchievement
Namespace Prefix: | zlab_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition License agreement date and year. + References No definition available. + Details
Name: | zlab_LicenseAgreementDateAndYear
Namespace Prefix: | zlab_
Data Type: | xbrli:gYearMonthItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount represents milestone payments. + References No definition available. + Details
Name: | zlab_MilestonePayments
Namespace Prefix: | zlab_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Number of milestone payments. + References No definition available. + Details
Name: | zlab_NumberOfMilestonePayments
Namespace Prefix: | zlab_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Payment of upfront fees for license agreement. + References No definition available. + Details
Name: | zlab_PaymentOfUpfrontFeesForLicenseAgreement
Namespace Prefix: | zlab_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=zlab_TesaroMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=zlab_ParatekBermudaLimitedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=zlab_FivePrimeTherapeuticsIncorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=zlab_EntasisTherapeuticsHoldingsIncorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=zlab_CrescendoBiologicsLtdMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=zlab_NovocureLimitedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=zlab_MacroGenicsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=zlab_DecipheraMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=zlab_IncyteMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=zlab_RegeneronPharmaceuticalsIncorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |